Search the Newsreel

World Acceptance director Benjamin Robinson sells $16,853 in shares By Investing.com

Benjamin Robinson, a director at World Acceptance Corp (NASDAQ:WRLD), sold 90 shares of the company's common stock for a total of $16,853. This insider sale follows a strong 46.6% return for WRLD shares over the past six months, despite InvestingPro analysis suggesting the stock …

World Acceptance Corp (WRLD) Director Robinson Benjamin E III Se

World Acceptance (WRLD) director trades 90 shares under 10b5-1 plan

World Acceptance Corp. director Benjamin E. Robinson III sold 90 shares of common stock on August 10, 2026, at $187.26 per share, under a Rule 10b5-1 trading plan. After this transaction, Robinson directly holds 4,746 shares of the company's common stock. The sale totaled …

Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results?

Accelerant Holdings ARX is set to report its second-quarter 2026 results on Aug. 13, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at 16 cents per share on revenues of $274.08 million. The second-quarter earnings estimate …

PACCAR Inc (PCAR) options chain

This article provides details on PACCAR Inc's (PCAR) options chain, including call and put prices for various strike prices and an ex-date for its cash dividend of $0.35 on August 12, 2026. It also shows PCAR's current stock performance, closing at $132.53, and lists …

British American Tobacco (LSE:BATS): Can Its Dividend Stay Resilient?

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History

This article provides comprehensive financial information for Accendra Health, Inc. (ACH), including its stock price, historical data, and recent news. It covers the company's profile as a healthcare solutions provider, its financial performance, earnings trends, and analyst insights. The data indicates significant negative returns …

Why Accord Financial Corp. stock surged yesterday

Research Analysts Offer Predictions for ACEL FY2026 Earnings

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

Baird has downgraded Accendra Health (ACH) from an "Outperform" rating to "Neutral" and significantly lowered its price target from $6 to $1.50. This change in rating and price target follows other recent analyst adjustments, indicating a more cautious outlook for the company. Accendra Health …

British American Tobacco (LON:BATS) Price Target Raised to GBX 3,800 at Royal Bank Of Canada

China Tobacco International (HK) Sets Board Meeting to Approve Interim Results and Consider Dividend

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results

This press release from Accendra Health reports their financial results for the second quarter of 2026. Further details on their performance would be contained within the full report.

Accent Resources (ASX: ACS) Shares up Over 600% - Here’s What Happening

Baird downgrades Accendra Health stock rating on weak results

Baird downgraded Accendra Health Inc. (NYSE:ACH) from Outperform to Neutral and cut its price target due to weak results and internal issues. The firm cited unreliable guidance, impending competitive bidding, and the company's micro-cap status with an active at-the-market offering program and poison pill. …

Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates

Accent Resources Cites Testwork Results in ASX Price Query Response

Credit Acceptance’s Q2 Earnings Call: Our Top 5 Analyst Questions

Credit Acceptance's Q2 Earnings Call: Our Top 5 Analyst Questions Credit Acceptance's second quarter results reflected a mix of margin expansion and modest loan volume improvements, even as revenue growth remained limited. Management highlighted that profitability gains stemmed from deliberate operational changes, including tighter …

ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6

Baird has downgraded Accendra Health Inc. to a Neutral rating from its previous Outperform rating. Concurrently, the investment firm significantly reduced its target price for Accendra Health Inc. shares to $1.50 from the prior $6.00. This adjustment indicates a revised outlook on the company's …

How PACCAR’s (PCAR) Higher Earnings on Slightly Lower Revenue Will Impact Investors

PACCAR (PCAR) reported higher Q2 2026 earnings despite slightly lower revenue, with sales of US$6,997 million and net income of US$752 million. This performance, along with back-to-back dividend increases, signals management's confidence in cash generation and supports the idea that strong margins can offset …

Accel Entertainment: Chicago Gaming Could Unlock Significant Earnings Upside (Rating Upgrade)

Accent Resources Halts ASX Trading Amid Unusual Share Activity

British American Tobacco PLC (BTI) Stock Down 3.8% but Still Overvalued -- GF Score: 78/100

British American Tobacco PLC (BTI) shares dropped 3.8% to $57.05, yet the stock remains significantly overvalued, trading 37.2% above its GF Value™ estimate of $41.59. Despite its decent profitability and momentum, BTI's GF Score™ of 78/100 reveals concerns regarding its financial strength and valuation. …

Paccar Inc. stock underperforms Monday when compared to competitors

Paccar Inc. (PCAR) stock declined by 1.40% on Monday, closing at $131.24, despite a generally grim trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average also saw slight declines. The company's stock is currently 5.75% below its 52-week …

Accendra Health Reports 111.1% Wider Q2 2026 Loss at -$0.19/Share

Accendra Health outlines $2.45B-$2.55B 2026 revenue and $300M-$320M adjusted EBITDA amid cost cuts and CEO retirement plan

Earnings Call Insights: Accendra Health (ACH) Q2 2026 MANAGEMENT VIEW * "Before I dive into our second quarter results and the outlook for the balance of the year, I'd like to take a moment to address the announcement included in today's press release that …

British American Tobacco plc Stock (BTI) Moved Down by 3.86% on Aug 10: Facts Behind the Movement

Why British American Tobacco (BTI) Stock Is Down Today

ACCENDRA HEALTH 2026: Revenue $613.23M, EPS ($1.16) — 10-Q Summary

ACCENDRA HEALTH (ACH) reported its second-quarter 2026 results, with net revenue of $613.23 million and a diluted loss per share of ($1.16). This represents a decline in revenue compared to the prior year, primarily due to the loss of a major commercial payor contract, …

Accendra Health Reports Lower Q2 Revenue, Sets 2026 Guidance; Adopts Tax Asset Plan; Stock Down

(RTTNews) - Accendra Health, Inc. (ACH) reported financial results for the second quarter ended June 30, 2026, showing a decline in revenue, as the company continues its transition following separation from Owens & Minor. Revenue for the quarter came in at $613.2 million, down …

Why Accord Financial Corp. stock is plummeting today

Accendra Health earnings missed by $0.31, revenue fell short of estimates

World Acceptance (WRLD) insider files to sell 90 shares after recent stock sales

World Acceptance (WRLD) insider Benjamin Robinson III has filed a Form 144 to sell 90 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $16,853.40. These shares were acquired as compensation in October 2023. Robinson III has made previous sales …

Accendra Health CEO to retire by end of the year

Accendra Health President and CEO Edward A. Pesicka announced his plan to retire by the end of the year after leading the company for over seven years, including its rebranding from Owens & Minor. The board is evaluating successors, and Pesicka may stay on …

Earnings call transcript: Accendra Health cuts 2026 outlook as shares sink in Q2 2026

Accendra Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:ACH) 2026-08-10